These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 11296960

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Corticosteroid-induced osteoporosis: does it occur in patients with Crohn's disease?
    de Jong DJ, Corstens FH, Mannaerts L, van Rossum LG, Naber AH.
    Am J Gastroenterol; 2002 Aug; 97(8):2011-5. PubMed ID: 12190169
    [Abstract] [Full Text] [Related]

  • 23. Tacrolimus and low-dose steroid immunosuppression preserves bone mass after renal transplantation.
    Goffin E, Devogelaer JP, Lalaoui A, Depresseux G, De Naeyer P, Squifflet JP, Pirson Y, van Ypersele de Strihou C.
    Transpl Int; 2002 Mar; 15(2-3):73-80. PubMed ID: 11935163
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Physician's awareness of the prevention of corticosteroid induced osteoporosis.
    Ungprasert S, Wangkaew S, Louthrenoo W.
    J Med Assoc Thai; 2007 Jan; 90(1):59-64. PubMed ID: 17621734
    [Abstract] [Full Text] [Related]

  • 29. Patient knowledge, beliefs, and behavior concerning the prevention and treatment of glucocorticoid-induced osteoporosis.
    Blalock SJ, Norton LL, Patel RA, Dooley MA.
    Arthritis Rheum; 2005 Oct 15; 53(5):732-9. PubMed ID: 16208664
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Influences on bone mineral density in Malaysian premenopausal systemic lupus erythematosus patients on corticosteroids.
    Yeap SS, Fauzi AR, Kong NC, Halim AG, Soehardy Z, Rahimah S, Chow SK, Goh EM.
    Lupus; 2009 Feb 15; 18(2):178-81. PubMed ID: 19151123
    [Abstract] [Full Text] [Related]

  • 33. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis.
    Arthritis Rheum; 2001 Jul 15; 44(7):1496-503. PubMed ID: 11465699
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Management of corticosteroid-induced osteoporosis.
    Drug Ther Bull; 2010 Sep 15; 48(9):98-101. PubMed ID: 20810708
    [Abstract] [Full Text] [Related]

  • 36. Inhaled corticosteroid-related tooth problems in asthmatics.
    Han ER, Choi IS, Kim HK, Kang YW, Park JG, Lim JR, Seo JH, Choi JH.
    J Asthma; 2009 Mar 15; 46(2):160-4. PubMed ID: 19253123
    [Abstract] [Full Text] [Related]

  • 37. Use of inhaled corticosteroids and bone mineral density in a population based study: the Nord-Trøndelag Health Study (the HUNT Study).
    Langhammer A, Norjavaara E, de Verdier MG, Johnsen R, Bjermer L.
    Pharmacoepidemiol Drug Saf; 2004 Aug 15; 13(8):569-79. PubMed ID: 15317039
    [Abstract] [Full Text] [Related]

  • 38. Pamidronate increases bone mineral density in women with postmenopausal or steroid-induced osteoporosis.
    Cauza E, Etemad M, Winkler F, Hanusch-Enserer U, Partsch G, Noske H, Dunky A.
    J Clin Pharm Ther; 2004 Oct 15; 29(5):431-6. PubMed ID: 15482386
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.